Resveratrol Ultra and Resveratrol Ultra High Potency: 2 Great Choices for Your Patients!

Resveratrol Ultra and Resveratrol Ultra High Potency are nutritional supplements containing pure trans-resveratrol, a plant compound which research suggests can activate siRT1, an enzyme associated with longevity.^†1 Both the original and high potency formula utilize specialized extraction and purification methods, providing higher potency and stability. The unique formulas contain synergistic combination of resveratrol and rutin (quercetin rutinoside) to provide more anti-aging and cellular health support than resveratrol alone.^†

Convenient for the sake of compliance.
Each supplement makes it easy for your patients:

• Potent anti-aging antioxidant that supports cellular, heart, and neurological health^†
• Synergistic formula combining resveratrol and rutin (quercetin rutinoside)
• One serving of Resveratrol Ultra (125 mg) contains as much trans-resveratrol as 80 bottles of red wine* and as much as 118 bottles of red wine in one serving of Resveratrol Ultra High Potency (175 mg)**

Resveratrol + Quercetin = Synergy.
Resveratrol Ultra anti-aging formulas contain rutin (quercetin rutinoside), a bioflavonoid from Japanese sophora (Sophora japonica) flower bud, which is converted to quercetin in the body. Research suggests that the combination of quercetin and resveratrol provides more potent support for the immune system than either compound alone.^†2,3

High-Potency Rejuvenation Formula.^†
One of the most effective ways to slow the pace of aging is a severe low calorie diet, which releases a longevity enzyme (siRT1) to help the body adapt. But few people can follow such a restrictive diet. Studies show that resveratrol duplicates the effects of calorie restriction and activates this enzyme without dieting.† That’s good news for your patients.

Additionally, siRT1 counters the effects of free radicals, shields the body from oxidative cell damage, speeds up cellular repair and supports a healthy heart – all additional benefits your patients can appreciate, too.^†

References:

1. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006;5:493-506.
2. Mertens-Talcott SU. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 2005;218(2):141-51.
3. Elattar TM, Virji AS. The effect of red wine and its components on growth and proliferation of human oral squamous carcinoma cells. Anticancer Res 1999;19:5407-14.

*Based on 125 mg trans-resveratrol dose, an average of 1.97 mg of trans-resveratrol per liter of red wine, and 750 mL bottle size.
**Based on 175 mg trans-resveratrol dose, an average of 1.97 mg of trans-resveratrol per liter of red wine, and 750 mL bottle size.